Teva Stock Falls After Earnings and Revenue Miss Estimates | Barron's
Teva Pharmaceutical Industries (TEVA) - Market capitalization
Teva Stock Skids As First-Quarter Sales Decline — Again | Investor's Business Daily
Teva's (TEVA) Q3 Earnings and Revenues Miss, Stock Down | Nasdaq
Positive Earnings Look as If They're Already Priced in to Teva Stock | InvestorPlace
Teva Pharmaceutical Is Reporting Earnings. Here's What to Expect. | Barron's
Teva buys Allergan's generic-drug unit for €40.5bn
Teva Pharmaceutical earnings per share 2006-2020 | Statista
Teva (TEVA) to Report Q1 Earnings: What's in the Cards?
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva Pharmaceutical Industries Limited 2021 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Drug firm Teva predicts 2017 revenue and profit below estimates
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Floundering Teva grabbed Allergan generics as a lifeline. It didn't work | FiercePharma
Teva Pharmaceutical Industries (NYSE:TEVA) investors are sitting on a loss of 77% if they invested five years ago | Nasdaq
Teva Pharmaceutical: Earnings Trends and Recent Developments
Teva soars after earnings beat, increased guidance - TheStreet
Teva Pharmaceutical Industries Limited 2021 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
